Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
52%
Total
Publications
403
Total Open
Publications
208
Total
Citations
7.4K
Open Access
Percentage
52%
Total
Publications
403
Total Open
Publications
208
Total
Citations
7.4K
Breakdown
Publisher Open
20%
Both
29%
Other Platform Open
2%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
60
Hybrid 40%
80
No Guarantees 30%
59
Other Platform Open
Domain 80%
101
Institution 49%
62
Other Internet 10%
12
Public 4%
5
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 104 |
doaj.org OAI-PMH Repository | Institution | 28 |
University of Groningen | Institution | 8 |
Europe PMC | Domain | 8 |
Unknown Repository | Other Internet | 6 |
DOI | Other Internet | 6 |
uj.edu.pl OAI-PMH Repository | Institution | 4 |
Harris County Public Library | Institution | 4 |
Figshare | Public | 4 |
California Digital Library | Institution | 4 |